Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - CAPITAL EXPENDITURES
Capital Expenditures TRVI - Trevi Therapeutics, Inc.
-137 K
LAST VALUE
0.00%
2 YEAR CAGR
2.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR